Vascular calcifications are influenced by changes in acid-base balance. Alkalinization is thought to promote calcium phosphate precipitation. Raising plasma bicarbonate(BIC) by dialysis in hemodialysis(HD) patients may lead to excessive correction of metabolic acidosis and promote vascular calcifications.Post-dialysis acid-base balance and calcium-phosphate alterations are described in HD patints with and without vascular calcifications. METHODS: 20 patients on standard HD with dialysate BIC and Ca 2þ concentrations of 32mM and 1,5mM respectively and serum PTH of 3406274pg/ml were studied. Calcification degree was scored using hands and pelvis X-ray films divided into four parts by mutually vertical lines. Each part could be scored 0 or 1 according to calcification absence or presence respectively and patients could get final calcification scores(CaS) from 0 to 8. Two patient groups were formed: group A(GA) included 11 patients with CaS1(0,1860,4) and group B(GB) 9 patients, with CaS>1(6,4461,8)-p<0,001. In all patients blood was sampled before(preD), at the end(postD) and one hour after session(1hpostD) for pH, BIC, ionized Ca(iCa), phosphate(P), total Ca, albumin(Alb), urea and Mg. Corrected for Alb Ca(Ca) and CaxP product values were calculated. RESULTS: In GA, postD pH(7,4260,05) and 1hpostD pH(7,4260,05) were higher than preD pH(7,3260,04)-p<0,001 respectively; BIC showed similar increases: 26,461,8 and 25,862,5 vs 20,561,9mM-p<0,001 respectively. Similarly in GB, postD pH(7,4360,05) and 1hpostD pH(7,4260,05) were higher than preD pH(7,3460,05)-p<0,001 respectively; BIC showed similar increases: 26,261,6 and 25,262,2 vs 21,562,4mM-p<0,001 respectively. In GA, only postD Ca(10,161mg/dl) was higher than preD Ca(8,960,7mg/dl)-p¼0,02; 1hpostD Ca(9,860,7mg/dl) was not statistically different from preD Ca or postD Ca, whereas both postD Alb(4,660,5g/dl) and 1hpostD Alb(4,560,4g/dl) were higher than preD Alb(460,3g/dl)-p<0,05 respectively. In contrary, in GB both postD Ca(10,360,5mg/dl) and 1hpostD Ca(10,360,9 mg/dl) were higher than preD Ca(9,2mg/dl)-p<0,05 respectively, whereas there was no significant changes in Alb. In both groups postD P was decreased: GA, 5,761,5 to 2,960,7mg/dl-p<0,001 and GB, 5,661,6 to 3,260,7mg/dl-p<0,001; 1hpostD P was also lower than preD P with no significant rebound: GA, 3,861,002 and GB, 3,860,004. CaxP values followed P changes in both groups. No difference between groups was observed in postD and 1hpostD iCa and Mg changes. In all patients significant negative correlations of 1hpostD Ca were observed with PTH(p¼0,04) and preD urea(p¼0,03). CONCLUSIONS: In conclusion, all patients experienced similar postD pH and BIC increases remaining one hour after session. Only patients with high calcification score had increased 1hpostD Ca under alkaline pH in the absence of Alb increase. The relationship of this finding with postD metabolic alkalosis in patients with vascular calcifications needs further investigation.
INTRODUCTION AND AIMS:
Vascular calcifications are influenced by changes in acid-base balance. Alkalinization is thought to promote calcium phosphate precipitation. Raising plasma bicarbonate(BIC) by dialysis in hemodialysis(HD) patients may lead to excessive correction of metabolic acidosis and promote vascular calcifications.Post-dialysis acid-base balance and calcium-phosphate alterations are described in HD patints with and without vascular calcifications. METHODS: 20 patients on standard HD with dialysate BIC and Ca 2þ concentrations of 32mM and 1,5mM respectively and serum PTH of 3406274pg/ml were studied. Calcification degree was scored using hands and pelvis X-ray films divided into four parts by mutually vertical lines. Each part could be scored 0 or 1 according to calcification absence or presence respectively and patients could get final calcification scores(CaS) from 0 to 8. Two patient groups were formed: group A(GA) included 11 patients with CaS1(0,1860,4) and group B(GB) 9 patients, with CaS>1(6,4461,8)-p<0,001. In all patients blood was sampled before(preD), at the end(postD) and one hour after session(1hpostD) for pH, BIC, ionized Ca(iCa), phosphate(P), total Ca, albumin(Alb), urea and Mg. Corrected for Alb Ca(Ca) and CaxP product values were calculated. RESULTS: In GA, postD pH(7,4260,05) and 1hpostD pH(7,4260,05) were higher than preD pH(7,3260,04)-p<0,001 respectively; BIC showed similar increases: 26, 461, 8 and 25, 862, 5 vs 20, 561, 001 respectively. Similarly in GB, postD pH(7, 4360, 05) and 1hpostD pH(7,4260,05) were higher than preD pH(7,3460,05)-p<0,001 respectively; BIC showed similar increases: 26,261,6 and 25,262,2 vs 21,562,4mM-p<0,001 respectively. In GA, only postD Ca(10,161mg/dl) was higher than preD Ca(8,960,7mg/dl)-p¼0,02; 1hpostD Ca(9,860,7mg/dl) was not statistically different from preD Ca or postD Ca, whereas both postD Alb(4,660,5g/dl) and 1hpostD Alb(4,560,4g/dl) were higher than preD Alb(460,3g/dl)-p<0,05 respectively. In contrary, in GB both postD Ca(10,360,5mg/dl) and 1hpostD Ca(10,360,9 mg/dl) were higher than preD Ca(9,2mg/dl)-p<0,05 respectively, whereas there was no significant changes in Alb. In both groups postD P was decreased: GA, 5,761,5 to 2,960,7mg/dl-p<0,001 and GB, 5,661,6 to 3,260,7mg/dl-p<0,001; 1hpostD P was also lower than preD P with no significant rebound: GA, 3,861,1mg/dl-p¼0,002 and GB, 3,860,8mg/dl-p¼0,004. CaxP values followed P changes in both groups. No difference between groups was observed in postD and 1hpostD iCa and Mg changes. In all patients significant negative correlations of 1hpostD Ca were observed with PTH(p¼0,04) and preD urea(p¼0,03). CONCLUSIONS: In conclusion, all patients experienced similar postD pH and BIC increases remaining one hour after session. Only patients with high calcification score had increased 1hpostD Ca under alkaline pH in the absence of Alb increase. The relationship of this finding with postD metabolic alkalosis in patients with vascular calcifications needs further investigation. 
Fractures are an important cause of morbidity and mortality in haemodialysis (HD) patients. The aim of this study was to quantify the incidence of bone fractures in a cohort of prevalent HD patients and evaluate its relationship with potential risk factors. METHODS: We performed a retrospective analysis of 341 prevalent HD patients since they started HD (median of 51 months). Demographic, clinical and biochemical parameters as well as vascular calcifications (VC) by Adragao score were evaluated. RESULTS: Fifty-seven episodes of fracture were identified with a median HD vintage of 47 months, which corresponds to an incidence rate of 31 per 1000 person-years. In a multivariable analysis age (p<0.001), female gender (p<0.001), lower albumin (p¼0.02) and a higher VC score (p<0.001) were independently associated with increased risk of fracture, while active vitamin D therapy (p¼0.03) was associated with a decreased risk.A significantly higher risk of incident fracture was also associated with higher values of bone-specific alkaline phosphatase (bAP) (p¼0.01) and intact parathyroid hormone (iPTH) levels either < 300 pg/mL (p¼0.02) or > 800 pg/mL (p<0.001) compared with 300-800 pg/mL. CONCLUSIONS: The incidence of bone fractures in HD patients is high and its risk increases with age, female gender, low serum albumin and with the presence of more VC. Prevalent HD patients with low or high iPTH levels or increased bAP also had a higher fracture risk. Unlike, therapy with active vitamin D seems to have a protective role. Assessment of fracture risk and management in dialysis patients at greatest risk requires further study. In fact, almost all of these studies lasted less than 36 weeks. We herein report our experience on the impact of cholecalciferol supplementation on PTH levels in a group of HD patients. METHODS: For this purpose 99 HD patients were treated with cholecalciferol at a dose of 25,000 IU p.o. weekly for 12 months. All patients had a SHPT condition defined as PTH levels > 300 pg / ml or PTH levels in optimal range but during therapy with cinacalcet or paricalcitol. At the end of follow-up, only 59 of the 99 patients had actually taken vitamin D supplementation, so that two groups were formed. Group A included patients treated with cholecalciferol (n¼59), while group B (n¼40) included no treated patients. Serum calcium, phosphorous, hemoglobin, and therapy with phosphate binders, cinacalcet, paricalcitol, and erythropoietin were assessed each month, while total alkaline phosphatase, vitamin D, and PTH levels were evaluated every 3 months. RESULTS: At baseline, 8 patients had a severe vitamin D deficiency (<5 ng/ml), 73 mild vitamin D deficiency (5-15 ng/ml), and 18 vitamin D insufficiency (16-30 ng/ml). Parathormone levels were negatively correlated with vitamin D levels (r¼-.178; P < 0.001). At F-U in the group A there was a significant reduction in PTH levels, from 462 6 327 to 351 6 282 pg/ml (P<0.05), and a significant increase in vitamin D levels, from 9.8 6 5.1 to 33.5 6 12.1 ng/ml ( P<0.001), while sCa, sPO4 and t-ALP levels did not change. In this group the mean doses of paricalcitol were significantly reduced, from 9.2 6 2.9 (n¼41) to 6.5 6 3.8 mg/w (n¼40) (P<0.001), while no significant changes were recorded in the mean doses of cinacalcet and phosphate binders. Moreover, in the group A there was a significant increased of Hb levels, from 11.5 6 1.2 to 12.2 6 1.1 gr/dl (P< 0.05), without modification of erythropoietin dosage. In the group B PTH and vitamin levels at F-U did no change, 507 6 398 vs 508 6 440 pg/ml (P¼NS), and 12.1 6 6.5 vs 10.2 6 5.0 ng/ml (P¼NS), respectively. In this group mean doses of cinacalcet increased significantly, from 23 6 17 (n¼14) to 44 6 17 (n¼14) mg/d (P<0.01), while paricalcitol doses increased, but not significantly, from 8.3 6 3.5 (n¼32) to 9.7 6 5.0 (n¼31) mg/w, no changes were recorded in phosphate binders and erythropoietin doses. CONCLUSIONS: Vitamin D deficiency in hemodialysis patients is very frequent and its correction is associated with a better control of SHPT, a reduction of paricalcitol doses and a better control of anemia. 
